Certificate of analysis · ILS Labs
IGF-1LR3 1mg — Certificate of Analysis
This is the certificate of analysis (COA) that ILS Labs issued for IGF-1LR3 1mg, batch PRIME1026, tested Oct 12, 2026. HPLC purity: 99.90%. Each COA covers one batch.
Key facts
99.90%HPLC purity
Independent third-party lab: ILS Labs
- HPLC purity
- 99.90%
- Lab
- ILS Labs
- Batch / lot
- PRIME1026
- Size
- 1mg
- Test date
- Report number
- COA-2026-LTPZNI
- Access code
- HLNLBMSM
- Tests
- Purity, identity and quantity (HPLC) · Fentanyl screen
To check this COA with ILS Labs: open portal.ils-lab.com/verify/8WTuY62a7nMCZM47 and look up report COA-2026-LTPZNI with access code HLNLBMSM.
The product
IGF-1LR3
View product
Reading this COA
- HPLC purity
- How much of the sample is the stated compound, measured by high-performance liquid chromatography.
- Identity
- Confirms the sample is the compound on the label (LC-MS or HPLC retention time, as the report states).
- Content
- How much compound the vial holds, next to the amount on the label.
Other COAs
- BPC-157 10mgBatch PRIME1026 · Oct 12, 202699.49%
- CJC-1295 no DAC + Ipamorelin 10mg, Batch PRIME1026Oct 12, 202699.94%
- CJC-1295 no DAC + Ipamorelin 20mgBatch PRIME1026 · Oct 12, 202699.91%
- GLP-2 TZ 10mgBatch PRIME1026 · Oct 12, 202699.90%
- GLP-2 TZ 20mgBatch PRIME1026 · Oct 12, 202699.90%
- GLP-3 RT 20mgBatch PRIME1026 · Oct 12, 202699.90%
COAs are published as the lab issues them. All products are for laboratory research use only.